Literature DB >> 8414183

Factors in the cerebrospinal fluid of multiple sclerosis patients interfering with voltage-dependent sodium channels.

H Brinkmeier, K H Wollinsky, M J Seewald, P J Hülser, H H Mehrkens, H H Kornhuber, R Rüdel.   

Abstract

The effect of cerebrospinal fluid (CSF) from patients with multiple sclerosis (MS) on voltage-dependent Na+ channels in human myoballs was studied. The transient Na+ currents, elicited by whole-cell depolarization from -85 to -20 mV, were decreased to 75-25% the control value in the presence of CSF from all 7 MS patients investigated. The effect was complete in about 5 s and was fully reversible on admission of standard external fluid. Such decrease was not or only to a minor extent observed with 10 out of 11 control CSFs from patients without inflammatory neurological disease. The origin of the factors interfering with the Na+ channels is unknown. It is suggested that, in addition to demyelination, impaired Na+ channel function might cause the symptoms in MS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8414183     DOI: 10.1016/0304-3940(93)90465-w

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Neurological channelopathies.

Authors:  M R Rose
Journal:  BMJ       Date:  1998-04-11

Review 2.  The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.

Authors:  K J Smith; W I McDonald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

3.  Local anaesthetic-like effect of interleukin-2 on muscular Na+ channels: no evidence for involvement of the IL-2 receptor.

Authors:  A Kaspar; H Brinkmeier; R Rüdel
Journal:  Pflugers Arch       Date:  1994-01       Impact factor: 3.657

4.  Serine-1321-independent regulation of the mu 1 adult skeletal muscle Na+ channel by protein kinase C.

Authors:  S Bendahhou; T R Cummins; J F Potts; J Tong; W S Agnew
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.